The study is a prospective multicenter registry. Consecutive patients with indications of implant / replacement or upgrade of implantable cardioverter defibrillator (ICD) will be enrolled. The primary objective of the study is to determine the predictors of appropriate anti-tachycardia therapy (with shock) in a non-selected population of patients implanted with an ICD. Secondary objectives of the study are: * the incidence of anti-tachycardia therapies; * the predictors of inappropriate therapy and onset of arrhythmia burden; * the adherence to the current guidelines in the Italian clinical practice; * the predictors of heart failure (HF) onset and response to cardiac resynchronization therapy (CRT).
Study Type
OBSERVATIONAL
Enrollment
10,000
Ospedale Papa Giovanni XXIII
Bergamo, Italy
RECRUITINGPoliclinico S.Orsola-Malpighi
Bologna, Italy
RECRUITINGP.O. Rodolico-San Marco
Catania, Italy
RECRUITINGAzienda Ospedaliero Universitaria Careggi
Florence, Italy
RECRUITINGASST Rhodense- Ospedale di Rho
Milan, Italy
RECRUITINGIRCCS S.Ambrogio-Galeazzi
Milan, Italy
RECRUITINGOspedale dei Colli Monaldi
Naples, Italy
RECRUITINGUniversity of Padua
Padua, Italy
RECRUITINGIRCC Policlinico San Matteo
Pavia, Italy
RECRUITINGAzienda Ospedaliero Universitaria Pisa Cisanello
Pisa, Italy
RECRUITING...and 2 more locations
Patients with ICD therapy (shock)
Clinical or instrumental parameters that could predict the appropriate ICD therapies
Time frame: 24 months
Patients with inappropriate shock therapy
Clinical or instrumental parameters that could predict the inappropriate ICD therapies
Time frame: 24 months
Incidence of ICD therapies
Number of patients with ICD therapies
Time frame: 24 months
Time to first ICD therapy
Time frame: 24 months
Predictors of onset and Atrial Fibrillation (AF) burden
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.